Back to Organizations
Nabla Bio
Nabla Bio is a Cambridge, Massachusetts AI drug-design company that combines generative molecular modeling with integrated wet-lab testing to develop antibody and other protein therapeutics.
Cambridge, United States
Current Funding Stage
Series ACurrent recognized equity stage. The rounds below remain the historical funding record.
Funding Rounds
Funding Round: Series A
Funding Date: 14 May, 2024
Raised Amount: $26M
Funding Round: Seed
Funding Date: 6 Dec, 2021
Raised Amount: $11M